Annsy Camila Arredondo Nuñez

Mrs. Annsy Camila Arredondo Nuñez

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Life
Verified
Journal Article
Open access
PDF file
ANAnnsy Camila Arredondo Nuñez
Annsy Camila Arredondo Nuñez
GMGisele Monteiro
Gisele Monteiro
CFCarol Nathali Flores Fernandez
Carol Nathali Flores Fernandez
LALina Antenucci
Lina Antenucci
PPPerttu Permi
Perttu Permi
AZAmparo Iris Zavaleta
Amparo Iris Zavaleta
L-asparaginases from bacterial sources have been used in antineoplastic treatments and the food industry. A type II L-asparaginase encoded by the N-truncated gene ansZP21 of halotolerant Bacillus subtilis CH11 isolated from Chilca salterns in Peru was expressed using a heterologous system in Escherichia coli BL21 (DE3)pLysS. The recombinant protein was purified using one-step nickel affinity chromatography and exhibited an activity of 234.38 U mg−1 and a maximum catalytic activity at pH 9.0 and 60 °C. The enzyme showed a homotetrameric form with an estimated molecular weight of 155 kDa through gel filtration chromatography. The enzyme half-life at 60 °C was 3 h 48 min, and L-asparaginase retained 50% of its initial activity for 24 h at 37 °C. The activity was considerably enhanced by KCl, CaCl2, MgCl2, mercaptoethanol, and DL-dithiothreitol (p-value < 0.01). Moreover, the Vmax and Km were 145.2 µmol mL−1 min−1 and 4.75 mM, respectively. These findings evidence a promising novel type II L-asparaginase for future industrial applications.

30 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ANAnnsy Camila Arredondo Nuñez
Annsy Camila Arredondo Nuñez
GMGisele Monteiro
Gisele Monteiro
CFCarol Nathali Flores Fernandez
Carol Nathali Flores Fernandez
LALina Antenucci
Lina Antenucci
PPPerttu Permi
Perttu Permi
AZAmparo Iris Zavaleta
Amparo Iris Zavaleta
L-asparaginase from bacterial sources have been used in antineoplastic treatments and the food industry. A novel type II L-a sparaginase encoded by the N-truncated gene ansZP21 of halotolerant Bacillus subtilis CH11 isolated from Chilca salterns in Peru was expressed using a heterologous system in Escherichia coli BL21 (DE3)pLysS. The recombinant protein was purified using one-step nickel affinity chromatography and exhibited activity of 234.38 U mg-1 and a maximum catalytic activity at pH 9.0 and 60 °C. The enzyme shows a homotetrameric form with an estimated molecular weight of 155 kDa by gel filtration chromatography. The enzyme half-life at 60 °C was 3 h 48 min, and L-asparaginase retained 50% of initial activity for 24 h at 37 °C. The activity was considerably enhanced by KCl, CaCl2, MgCl2, mercaptoethanol, and DL-dithiothreitol (p-value < 0.01). Moreover, the Vmax and Km were 145.2 µmol mL-1 min-1 and 4.752 mM, respectively. These findings evidence a promising novel type II L-asparaginase for future industrial applications.

14 August 2024 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
CBCesar Bautista
Cesar Bautista
ANAnnsy Camila Arredondo Nuñez
Annsy Camila Arredondo Nuñez
Arturo IntiquillaArturo Intiquilla
Arturo Intiquilla
CFCarol Nathali Flores Fernandez
Carol Nathali Flores Fernandez
ABAdriano Brandelli
Adriano Brandelli
AZAmparo Iris Zavaleta
Amparo Iris Zavaleta

29 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
LALina Antenucci
Lina Antenucci
CTChandan Thapa
Chandan Thapa
SVSalla Virtanen
Salla Virtanen
TLTimo A. Lehti
Timo A. Lehti
ANAnnsy Camila Arredondo Nuñez
Annsy Camila Arredondo Nuñez
PPPerttu Permi
Perttu Permi
Emergence of antimicrobial resistance is a pressing global issue. Although myriads of mechanisms for survival against antimicrobial pressure have surfaced, one key strategy is the structural modification of peptidoglycan, the main defense line in Gram-positive bacteria e.g., notorious pathogen Staphylococcus aureus . Here we show that the recently identified peptidoglycan hydrolase (PGH) LytU is an unusual catalyst in the lysostaphin (M23B) family of zinc-endopeptidases that hydrolyze the glycyl-glycine peptide bond in S. aureus . Unlike any other PGH recognized thus far, LytU hydrolyzes the isopeptide bond between the lysine ε amino group and pentaglycine, thus functioning as a bridge-link hydrolase. We discovered that LytM and LytU are functionally non-redundant, and they contribute to the cell wall remodeling at different stages of PG maturation. Additionally, we demonstrate that LytU particularly targets the PG precursor, pGly-Lipid II, and its overexpression leads to growth inhibition and a less densely cross-linked cell wall, which increases susceptibility to lysostaphin. Interestingly, LytU expression enhances resistance to the glycopeptide vancomycin, the drug of last resort against S. aureus .